Form 4: Elevance Health Director Deanna D Strable-Soethout Reports Acquisition of Deferred Stock Units

Deanna D Strable-Soethout, a director of Elevance Health, Inc., reported the acquisition of deferred stock units under the company's Board of Directors Compensation Program.

Summary

• On May 14, 2025, Deanna D Strable-Soethout, a director of Elevance Health, Inc., acquired 601 deferred stock units.
• These units were accrued under the Elevance Health, Inc. Board of Directors Compensation Program.
• The deferred stock units will be payable in Company common stock upon the earlier of (a) five years from the grant date or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
• Following the transaction, Strable-Soethout beneficially owns 1,646 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The acquisition of deferred stock units can be seen as a positive sign of alignment between the director and the company's long-term interests.

Positives

• The acquisition of deferred stock units aligns the director's interests with the long-term performance of Elevance Health.
• The structure of the deferred stock units encourages continued service on the board.

Future Outlook

The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

This filing is a routine disclosure related to director compensation and is typical for publicly traded companies. It reflects standard practices for aligning director interests with shareholder value through equity-based compensation.

Stakeholder Impact

• The acquisition of deferred stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates

Keywords

Elevance Health, Director, Deferred Stock Units, Beneficial Ownership, Form 4, Compensation Program, ELV, Strable-Soethout